Benefiting From the...
Health Care: Health Services
Heartware International Inc. (HTWR: NASDAQ)
$92.81 -2.24 | -2.36%
05/22/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 95.05 |
| 52 Week High | 99.68 |
| 52 Week Low | 74.77 |
| Avg. Daily Vol. (Mil) | 0.25 |
| Beta (3 year) | -0.19 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,553.65 |
| Shares Out (Mil) | 16.35 |
| Float (Mil) | 12.06 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 8.70 |
| Current Ratio | 10.10 |
| LT Debt/ Equity | 0.50 |
| Total Debt / Equity | 0.50 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 11.61 |
| Price/Book | 7.69 |
| Price/Cash Flow | -14.00 |
| Per Share Data | |
| Earnings | -5.68 |
| Sales | 8.19 |
| Book Value | 12.36 |
| Cash Flow | -6.78 |
| Business Summary | |
|---|---|
| A medical device Company developing a family of implantable Left Ventricular Assist Devices for the treatment of advanced heart failure. | |
| General Information | |
| 205 Newbury Street
Suite 101 Framingham, MA 01701 |
|
| www.heartware.com.au | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 396 | |
| CEO: Mr. Douglas Godshall | |
| Short Interest | |
| Current Month (Mil) | 1.97 |
| Previous Month (Mil) | 1.95 |
| Short Interest Ratio (Days) | 7.60 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -36.50 |
| Return on Investments | -40.00 |
| Profitability | |
| Gross Margin | 65.40 |
| EBIT Margin | -52.50 |
| Profit Margin | -92.30 |
Portfolios with HTWR
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Small-Cap Stocks That Ma...
- UserPART 6 JPMorgan 28th Annual...
Latest HTWR Headlines from TheStreet
- 3 Stocks Spiking on Big Volume 03.13.13 | 02:03 pm
- Analysts' Actions: EV FRC GLRE HTWR HPQ 11.21.12 | 08:11 am
- 4 Notables Rising on Unusual Volume 11.12.12 | 03:11 pm
- Sunshine Heart: A Promising Treatment for Heart Failure Patients 11.05.12 | 08:11 am
- Insiders Trading IMAX, HTWR, NAV, ABM 07.17.12 | 11:07 am
- 8 Stocks Ripping Higher on Big Volume 05.11.12 | 01:05 pm
- 8 Stocks Rising on Monster Volume 04.23.12 | 03:04 pm
- Heartware International Stock Hits New 52-Week Low (HTWR) 09.12.11 | 10:09 am
- Heartware International Stock Hits New 52-Week Low (HTWR) 08.22.11 | 11:08 am
- Heartware International Stock Hits New 52-Week Low (HTWR) 08.04.11 | 12:08 pm
Press Releases for HTWR
- HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast - PR Newswire 05.16.13 | 04:05 pm
- HeartWare Presentation At The Bank Of America Merrill Lynch 2013 Health Care Conference To Be Webcast - PR Newswire 05.10.13 | 01:05 pm
- HeartWare Schedules First Quarter Conference Call And Webcast - PR Newswire 04.15.13 | 06:04 am
- HeartWare International, Inc. Announces Closing Of Public Offering Of Common Stock - PR Newswire 03.18.13 | 12:03 pm
- HeartWare International, Inc. Announces Pricing Of Public Offering Of Common Stock - PR Newswire 03.12.13 | 08:03 pm
- HeartWare International, Inc. Announces Public Offering Of Common Stock - PR Newswire 03.11.13 | 04:03 pm
- HeartWare Presentation At The Barclays Capital 2013 Global Healthcare Conference To Be Webcast - PR Newswire 03.06.13 | 09:03 am
- HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be Webcast - PR Newswire 02.28.13 | 10:02 am
- HeartWare Schedules Fourth Quarter Conference Call And Webcast - PR Newswire 02.19.13 | 08:02 am
- HeartWare Presentation At Leerink Swann Global Healthcare Conference To Be Webcast - PR Newswire 02.08.13 | 07:02 am
Partner Headlines for HTWR
- UPDATE: Goldman Sachs Reiterates Neutral Rating, Lowers PT on HeartWare International - Benzinga 12.03.12 | 09:12 am
- Stocks Hold Modest Gains; Stratasys Breaks Out - Investor's Business Daily 11.21.12 | 01:11 pm
- UPDATE: Wedbush Securities Raises PT to $105 on HeartWare International as FDA Approves HVAD - Benzinga 11.21.12 | 01:11 pm
- Thoratec Achieves 52-Week High - Analyst Blog - Zacks 11.05.12 | 06:11 pm
- Heart Failure: 'New Epidemic' Creates New Opportunities For Investors - Seeking Alpha 11.04.12 | 08:11 am
- Abiomed Reaffirmed at Neutral - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
- Thoratec Downgraded to Neutral - Analyst Blog - NASDAQ 08.22.12 | 07:08 pm
- UPDATE: Wunderlich Reiterates Hold Rating, Raises PT on HeartWare International - Benzinga 08.08.12 | 01:08 pm
- UPDATE: Piper Jaffray Raises PT on HeartWare International from $88 to $93 - Benzinga 08.08.12 | 09:08 am
- UPDATE: Goldman Sachs Initiates HeartWare International with Neutral - Benzinga 07.13.12 | 01:07 pm
